About the disease, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Example for this section: "we are developing small molecule regenerative medicines for [...]”

Program
Indication
Discovery
Hit
Lead
Candidate
IND-enabling
Clinical
TOR-101
Indication:
Viral Respiratory Tract Infections
Phase:
IND-enabling
TOR-101
Indication:
Oncology
Phase:
IND-enabling
TOR-103
Indication:
Viral Respiratory Tract Infections
Phase:
Candidate
TOR-103
Indication:
Oncology
Phase:
Candidate
TOR-104
Indication:
Autoimmune Disease
Phase:
Lead
TOR-105
Indication:
Dermatology
Phase:
Lead